A Study of Lasmiditan in Healthy Chinese Participants
Clinical trial NCT04081324 · COMPLETED
Trial details
- NCT number
- NCT04081324
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-13
- Primary completion
- 2020-06-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.